290 related articles for article (PubMed ID: 17517629)
1. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
[TBL] [Abstract][Full Text] [Related]
2. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
[TBL] [Abstract][Full Text] [Related]
3. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.
Corver WE; van Wezel T; Molenaar K; Schrumpf M; van den Akker B; van Eijk R; Ruano Neto D; Oosting J; Morreau H
Genes Chromosomes Cancer; 2014 Oct; 53(10):833-44. PubMed ID: 24909752
[TBL] [Abstract][Full Text] [Related]
4. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
5. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
6. Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
Cavadas B; Pereira JB; Correia M; Fernandes V; Eloy C; Sobrinho-Simões M; Soares P; Samuels DC; Máximo V; Pereira L
Mitochondrion; 2019 May; 46():123-133. PubMed ID: 29631022
[TBL] [Abstract][Full Text] [Related]
7. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients.
Lyu L; Wang Q; Song S; Li L; Zhou H; Li M; Jiang Z; Zhou C; Chen G; Lyu J; Bai Y
Mitochondrion; 2019 Mar; 45():1-6. PubMed ID: 29386142
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
9. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
Pereira L; Soares P; Máximo V; Samuels DC
BMC Cancer; 2012 Feb; 12():53. PubMed ID: 22299657
[TBL] [Abstract][Full Text] [Related]
10. An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.
Gasparre G; Iommarini L; Porcelli AM; Lang M; Ferri GG; Kurelac I; Zuntini R; Mariani E; Pennisi LF; Pasquini E; Pasquinelli G; Ghelli A; Bonora E; Ceccarelli C; Rugolo M; Salfi N; Romeo G; Carelli V
Hum Mutat; 2009 Mar; 30(3):391-6. PubMed ID: 19086058
[TBL] [Abstract][Full Text] [Related]
11. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.
Kurelac I; MacKay A; Lambros MB; Di Cesare E; Cenacchi G; Ceccarelli C; Morra I; Melcarne A; Morandi L; Calabrese FM; Attimonelli M; Tallini G; Reis-Filho JS; Gasparre G
Hum Mol Genet; 2013 Jan; 22(2):226-38. PubMed ID: 23049073
[TBL] [Abstract][Full Text] [Related]
12. Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference?
Tsybrovskyy O; Rössmann-Tsybrovskyy M
Histopathology; 2009 Dec; 55(6):665-82. PubMed ID: 20002768
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
Conti L; Vatrano S; Bertero L; Masu L; Pacchioni D; Daniele L; De Rosa G; Cassoni P; Volante M; Papotti M
Hum Pathol; 2017 Nov; 69():23-30. PubMed ID: 28962946
[TBL] [Abstract][Full Text] [Related]
15. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
16. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.
Yeh JJ; Lunetta KL; van Orsouw NJ; Moore FD; Mutter GL; Vijg J; Dahia PL; Eng C
Oncogene; 2000 Apr; 19(16):2060-6. PubMed ID: 10803467
[TBL] [Abstract][Full Text] [Related]
17. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors.
Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y
Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504
[TBL] [Abstract][Full Text] [Related]
18. Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors.
Zhang J; Yu W; Ryu SW; Lin J; Buentello G; Tibshirani R; Suliburk J; Eberlin LS
Cancer Res; 2016 Nov; 76(22):6588-6597. PubMed ID: 27659048
[TBL] [Abstract][Full Text] [Related]
19. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.
Tallini G; Ladanyi M; Rosai J; Jhanwar SC
Cytogenet Cell Genet; 1994; 66(4):253-9. PubMed ID: 7909283
[TBL] [Abstract][Full Text] [Related]
20. Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.
Mete O; Asa SL
Endocr Pathol; 2010 Mar; 21(1):16-24. PubMed ID: 20013317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
